Status:

WITHDRAWN

T-MACS Decision Aid: a Randomized, Controlled Point of Care Trial

Lead Sponsor:

Manchester University NHS Foundation Trust

Conditions:

Heart Attack

Chest Pain

Eligibility:

All Genders

18-100 years

Phase:

NA

Brief Summary

The aim of the study is to establish whether the safety of the T-MACS decision aid to immediately 'rule out' acute coronary syndromes with one blood sample for the cardiac damage marker troponin, is n...

Detailed Description

We will conduct a randomized, controlled point of care trial embedded in routine practice. We will ask clinicians to obtain written informed consent during the course of their clinical duties. Patient...

Eligibility Criteria

Inclusion

  • \>18 years of age
  • Presents to the Emergency Department with pain, discomfort or pressure in the chest, epigastrium, neck, jaw, or upper limb without an apparent non-cardiac source which the treating physician believes warrants investigation for possible acute coronary syndrome
  • The patient is identified as being at 'very low risk' by the T-MACS decision aid following a single hs-cTn test at the time of arrival in the Emergency Department

Exclusion

  • No capacity to provide informed consent
  • Inability to communicate in English language if translation services are unavailable
  • Patient is a prisoner
  • No NHS number (precluding electronic follow up)

Key Trial Info

Start Date :

January 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2021

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04313465

Start Date

January 1 2021

End Date

August 1 2021

Last Update

January 26 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Manchester University NHS Foundation Trust

Manchester, United Kingdom